GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 5,157 | 7,160 | 5,891 | 126,856 | 1,285 |
| Operating Income | -5,157 | -7,160 | -5,891 | -126,856 | -1,285 |
| Interest Expense | 3,924 | 2,931 | 135 | 3,769 | 1,178 |
| Pre-tax Income | -9,081 | -10,091 | -6,026 | -130,625 | -2,463 |
| Net Income Continuous | -9,081 | -10,091 | -6,026 | -130,625 | -2,463 |
| Net Income | $-9,081 | $-10,091 | $-6,026 | $-130,625 | $-2,463 |
| EPS Basic Total Ops | -91.93 | -102.14 | 15,857.69 | -4,162.33 | -2,625.07 |
| EPS Basic Continuous Ops | -92.54 | -102.83 | 15,862.29 | -4,162.22 | -2,626.08 |
| EPS Diluted Total Ops | -91.93 | -102.14 | 15,857.69 | -4,162.33 | -2,625.07 |
| EPS Diluted Continuous Ops | -92.54 | -102.83 | 15,862.29 | -4,162.22 | -2,626.08 |
| EBITDA(a) | $-966 | $-4,087 | $-5,768 | $-123,440 | $-723 |